Year None20232022202120202019201820172016201520142013201220112010 Date Title View February 27, 2023 Apexigen Announces Review of Strategic Alternatives and Restructuring January 24, 2023 Apexigen Announces Approximately $2.8 Million Private Placement Financing January 19, 2023 Apexigen Announces New Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, at ASCO Gastrointestinal Cancers Symposium 2023
